CAM use in dermatology. Is there a potential role for honey, green tea, and vitamin C?

Barbosa, Naiara S.; Kalaaji, Amer N.

doi:10.1016/j.ctcp.2013.11.003

Cited by 21 publications

(19 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is high in dermatological patients [26,27,28], particularly in those with chronic, inflammatory dermatoses [20]. Thus, it can be assumed that CAM use is highest in patients who need TCS the most.…”

Section: Discussionmentioning

confidence: 99%

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

Müller

Tomaschett²,

Euler³

et al. 2016

Dermatology

View full text Add to dashboard Cite

Background/Aims: Topical corticosteroid concerns (TCC) are an important issue in patients with atopic dermatitis, leading to non-adherence with poor disease control and increased health care costs. However, neither the prevalence of TCC in a more comprehensible dermatological population nor the impact of patient information on topical corticosteroids given by clinicians is known. Therefore, we assessed the prevalence, characteristics, and sources of TCC in a dermatological population and the impact of written and oral patient information on TCC. Methods: A total of 643 outpatients with various skin diseases answered a 12-item questionnaire while waiting for the doctor's visit. Patients with TCC quantified their concerns on a discrete visual analogue scale before and after patient information, which consisted of written and oral information about topical corticosteroids (TCS) given by dermatologists. Results: The prevalence of TCC was 41.5%, and that of TCC-related non-adherence was 28.3%. TCC was positively associated with age <60 years, female gender, use of complementary and alternative medicine (CAM) and non-physician health care profession. The leading concerns were skin atrophy, systemic effects, and impairment of the immune system. The most frequent sources of TCC were negative reports by media, family, or friends. Both written and oral patient information significantly reduced TCC. The number needed to benefit from patient information was approximately 2. Non-responders were more often female, TCS-inexperienced, and users of CAM with an intermediate level of education. Conclusions: TCC are highly prevalent in dermatological patients. Patient information may lower TCC in almost every second patient.

show abstract

Section: Discussionmentioning

confidence: 99%

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

Müller

Tomaschett²,

Euler³

et al. 2016

Dermatology

View full text Add to dashboard Cite

show abstract

“…The unique antibacterial, anti-inflammatory, and antioxidant properties of honey were found to contribute to wound healing, especially in ulcers and burns [72]. A large number of publications and text books in the twenty-first century evidenced the properties of honey in wound management [in veterinary and human] and other medical applications of honey [73].…”

Section: Wound Healing Property Of Honeymentioning

confidence: 99%

The anti-inflammatory and wound healing properties of honey

Hadagali

Chua

2014

Eur Food Res Technol

View full text Add to dashboard Cite

“…Vitamin C is an antioxidant useful for preventing and treating skin aging. It stimulates the barrier function of the endothelial cells and is proven to have photo protective effects [41,42]. What hampers its uses widely is the inability to delivery into the dermis for collagen production [43].…”

Section: Resultsmentioning

confidence: 99%

Metadichol® and Healthy Skin: One Approach many Possible Cures

Raghavan¹

2018

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

Metadichol ® a nano formulation of long-chain lipid alcohols derived from food. It is an inverse agonist of Vitamin D Receptor (VDR), Aryl Hydrocarbon Receptor (AHR), and Ror Game (RORC) that could have beneficial effects on skin diseases. We now present case studies of patents with various skin disease show Metadichol is an inverse agonist of these nuclear receptors thus modulating Th1 pathway towards a TH2 and Th 17 and IL 17 and IL22 and also being a TNF alpha inhibitor can modulate IL23 thus blocking the major pathways that exacerbate many Skin diseases. Metadichol is the first molecule successfully navigates around the problems involved with promiscuous ligands and targets. It fulfils the goals of the emerging field of Poly pharmacology, i.e. a single drug is able to bind to multiple targets beyond the "one drug, one target" philosophy. We show how Metadichol is an innovative treatment for treating multiple skin diseases eczema, acne, diabetic wounds and viral and bacterial infection and also improving skin texture. Metadichol ® is a safe nontoxic low cost solution and is an alternative to numerous clinical candidates in combating over 3000 skin diseases. Figure 1: Representation of International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes.

show abstract

CAM use in dermatology. Is there a potential role for honey, green tea, and vitamin C?

Cited by 21 publications

References 31 publications

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

The anti-inflammatory and wound healing properties of honey

Metadichol® and Healthy Skin: One Approach many Possible Cures

Contact Info

Product

Resources

About